Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study (NCT06161415)
Safety, Tolerability, and Distribution of Topical Laquinimod Eye Drops , an Innovative ImmunomodulatOr Targeting Aryl hydrocarboN Receptor (AhR): The LION Study
🩺 Plain-English Summary (8th-Grade Level)
The LION Study is a prospective, single-center phase 1 clinical trial to evaluate the safety, tolerability, and distribution of Laquinimod administered as topical eye drops for two weeks in human participants.
Who can join: Review the eligibility criteria below.
Location: Spencer Center for Vision Research at the Byers Eye Institute — Palo Alto, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Spencer Center for Vision Research at the Byers Eye Institute — Palo Alto, California
📞 Contact the Study Coordinator
Phone: (650) 723-6995
Email: nguyenlabtrials@stanford.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Inflammation
- An Open-Label Pilot Study of Qualia Senolytic Supplementation for the Attenuation of Systemic Inflammatory Cytokines — Carlsbad, California
- Evaluating the Ability of a Multi-Strain Postbiotic to Impact Inflammation, Immune Components, Gastrointestinal Symptoms, Recovery, Anxiety, and Intestinal Permeability — Saint Charles, Missouri
- Natural History of the Human Biological Response to Environmental Exposure and Injury — Research Triangle Park, North Carolina
- Targeting Vascular INflammation in Patients With Community-Acquired Pneumonia — Ottawa, Ontario
- Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil) — New York, New York
- Analysis of Inflammatory Biomarker Changes in Dry Blood Spot Versus Venous Blood Samples — Montreal, Quebec
Explore by condition: All Inflammation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.